Sheaff Brock Investment Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,250	Closed	-$204K	–	470
2024 Q1	$204K	Buy	+5,250	New	+$184K	0.01%	440
2019 Q3	–	Sell	-17,650	Closed	-$232K	–	472
2019 Q2	$232K	Sell	17,650 -3,000	-15%	-$40.1K	0.02%	389
2019 Q1	$313K	Buy	20,650 +2,675	+15%	+$42.8K	0.04%	333
2018 Q4	$309K	Sell	17,975 -8,250	-31%	-$141K	0.05%	318
2018 Q3	$387K	Sell	26,225 -775	-3%	-$13.7K	0.04%	310
2018 Q2	$644K	Buy	27,000 +15,450	+134%	+$380K	0.06%	219
2018 Q1	$295K	Buy	+11,550	New	+$275K	0.03%	360

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Sheaff Brock Investment Advisors's COLL Position: Q2 2024 in Review

Sheaff Brock Investment Advisors sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 5,250 shares — an estimated $204K sold.

Sheaff Brock Investment Advisors first reported a position in COLL in Q1 2018 and held it in 7 quarters. The position peaked at $644K in Q2 2018. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

Sheaff Brock Investment Advisors reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
Sheaff Brock Investment Advisors sold 5,250 Collegium Pharmaceutical shares in Q2 2024, an estimated $204K.
Sheaff Brock Investment Advisors first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 7 quarters.
Sheaff Brock Investment Advisors's Collegium Pharmaceutical position peaked at $644K in Q2 2018.
229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on Sheaff Brock Investment Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.